By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Medivation, Inc. 

525 Market Street
36th Floor
San Francisco  California  94105  U.S.A.
Phone: 415-543-3470 Fax: 415-543-3411


SEARCH JOBS

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzheimer's disease and a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also known as hormone-refractory) prostate cancer. Medivation recently announced that it plans to continue further development of Dimebon in patients with mild-to-moderate Huntington's disease based on the positive results seen in its Phase 2 trial.

For more information, please visit us at http://www.medivation.com/

YEAR FOUNDED:

October 1995

LEADERSHIP:

Founders: Clarence Patrick and David Hung

CEO and Co-founder: David Hung

CMO (Medical): Mohammad Hirmand

CFO: Jennifer Jarrett

JOBS:

Please click here for medivation job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.

PRODUCTS:

All Productions



Key Statistics


Email: info@medivation.com
Ownership: Public

Web Site: Medivation
Employees: 18
Symbol: MDVN
 





Collaborations

Pfizer 





Company News
Medivation (MDVN) Exec Jumps Ship to Become CMO at BeiGene (BGNE) 8/25/2016 6:52:40 AM
Just Days after a $14 Billion Medivation (MDVN) Buy, Pfizer (PFE) Buys AstraZeneca PLC (AZN)'s Antibiotics Business for $1.5 Billion-Plus 8/24/2016 5:37:05 AM
A Look at the Winners and Losers of Medivation (MDVN)'s $14 Billion Pfizer (PFE) Buyout Deal 8/23/2016 5:43:32 AM
Pfizer (PFE) Scoops Sanofi (SNY) With $14 Billion Buyout Deal for Medivation (MDVN) 8/22/2016 5:31:24 AM
Merck & Co. (MRK) Throws Hat Into Ring for Medivation (MDVN) 8/17/2016 11:34:11 AM
Sanofi (SNY) Even More Determined to Wrap Up Medivation (MDVN) Deal as Earnings Drop 7/29/2016 6:45:16 AM
AstraZeneca PLC (AZN) Mulls $10 Billion Bid for Medivation (MDVN) 7/11/2016 9:45:48 AM
REMINDER: Medivation (MDVN) To Host Conference Call And Webcast Providing Detailed Review Of Talazoparib On July 6, 2016 7/6/2016 9:06:36 AM
With Jobs at Stake, Medivation (MDVN) Inks Confidentiality Deals With Sanofi (SNY), Pfizer (PFE) and Celgene (CELG) 7/6/2016 5:51:09 AM
Medivation (MDVN) Shareholders May Turn Down Sanofi (SNY)'s Bid 6/27/2016 7:37:45 AM
12345678910...
//-->